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aorta, one or both pulmonary arteries, and the coronary
arteries. The anulus of the truncal valve is larger than a
normal semilunar valve and is placed in the normal aor-
tic position. In the majority of cases, the semilunar
valve has 2 to 4 cusps, and in rare instances valves with
5 cusps have been reported (tricuspid, 70%; tetracuspid,
23%; bicuspid, 6%; pentacuspid, 2%).1 In addition to
the abnormal number of cusps, there may be commis-
sural imperfection and nodularity causing prolapse.2
Primary repair of truncus arteriosus during the neona-
tal period and infancy has become the established prac-
tice.3,4 The excellent results of surgical repair of truncus
arteriosus reported in most centers have not applied to
those patients with significant truncal valve regurgita-
tion and associated interrupted arch. Truncal valve dys-
function is estimated to occur in up to 25% of patients
with truncus arteriosus.5 This figure may be an under-
T runcus arteriosus is a rare congenital heart malfor-mation that results from failure of septation of the
embryonic truncus arteriosus and failure of normal sep-
tation of the conus. A single arterial trunk leaves the
heart through a single semilunar valve and supplies the
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estimation of truncal valve dysfunction because of the
large runoff of blood to the pulmonary circulation. In
some series, valve regurgitation was identified by poor
hemodynamic performance when the patient was
weaned from cardiopulmonary bypass (CPB). The sur-
gical options for truncal valve regurgitation have been
homograft replacement with coronary reimplantation,
mechanical valve replacement, and valve repair. The
first two options condemn the patient to multiple fur-
ther operations with risks of eventual valve failure,
anticoagulation, and prosthetic valve endocarditis. The
recently reported disappointing results of homograft
valve replacement6,7 make truncal valve repair a more
attractive option. In an earlier series from Children’s
Hospital, Boston, truncal valve regurgitation and inter-
rupted aortic arch were identified as risk factors for
perioperative death.3
The purpose of this study was to examine the treat-
ment of patients with truncal valve regurgitation and
interrupted aortic arch in the current era and to compare
the outcome in these cases with that in the less complex
forms of truncus arteriosus.
Patients and methods
In the previous published series of truncus arteriosus from
Children’s Hospital, Boston, the cases of patients who had
undergone repair between September 1986 and December
1991 were reviewed.3 The current series encompasses
January 1992 to September 1998. The hospital records of all
patients who underwent repair of truncus arteriosus between
January 1992 and August 1998 were reviewed. There were no
patients with the diagnosis of truncus arteriosus who died
before operation. Fifty patients were identified: 31 boys and
19 girls. The ages ranged from 2 days to 6 months (median, 2
weeks). Weights ranged from 1.6 kg to 6.1 kg (median, 3.1
kg). Three patients were born prematurely, 2 at 31 weeks’
gestation and 1 at 30 weeks’ gestation, weighing at birth 1.6,
1.6, and 1.4 kg, respectively. All patients underwent primary
repair. Diagnosis was made in all patients by transthoracic
echocardiography alone. Repair was achieved in 37 patients
(74%) in the first month of life. The delayed repair in the
remainder was because of late referral. Associated cardiac
anomalies are shown in Table I.
Surgical technique. The repair was done with the use of
deep hypothermia with continuous CPB or reduced flow usu-
ally with a single venous cannula. A period of circulatory
arrest was used in 15 patients (30%). The CPB, crossclamp,
and circulatory arrest times are shown in Table II. The trun-
cus was usually divided at the level of takeoff of the pul-
monary arteries and great care was taken to ensure that an
adequate margin from the coronary arteries was maintained.
The truncal root was anastomosed to the ascending aorta.
This necessitated considerable tailoring of the large truncal
root, which may have improved valve leaflet apposition. The
ventricular septal defect was approached through the right
ventriculotomy and was closed with interrupted pledget-sup-
ported sutures using glutaraldehyde-treated autologous peri-
cardium or Dacron fabric. The right ventricular outflow tract
was reconstructed with either an aortic or pulmonary homo-
graft. The patent foramen ovale was left open, and if this was
not patent a small atrial communication was made.
Patients with truncal valve regurgitation. Fourteen
patients (28%) with truncal valve regurgitation were identi-
fied preoperatively. Of the 14 patients, 5 had mild regurgita-
tion, 5 had moderate regurgitation, and 4 had severe regurgi-
tation. Five patients with moderate to severe regurgitation
underwent valve repair and 1 patient underwent homograft
root replacement. Three patients with moderate truncal valve
regurgitation did not undergo repair. These patients were
from the earlier part of the series when truncal valve prob-
lems were not specifically addressed.
The principle of valve repair was improved leaflet apposi-
tion. This was achieved by approximation of the incomplete
commissures and resuspension of the true commissures. The
rudimentary commissures were closed with 7-0 Prolene
polypropylene sutures supported with pericardial pledgets. If
there was some redundancy in the anulus, this was reduced by
taking a tuck at the attachment of the raphe of the commis-
sure and the aortic wall. Reduction of the sinuses of Valsalva
was done when indicated. Three patients had quadricusp
valves, in which 2 cusps were relatively normal and the other
2 cusps were partially fused at a rudimentary commissure.
One patient had 5 leaflets with 3 large leaflets and 2 addi-
tional leaflets. The fifth patient had a bicuspid valve. A 5-day-
old neonate weighing 2.9 kg with severe truncal valve regur-
gitation underwent homograft root replacement (aortic
homograft, 11 mm) with coronary reimplantation. This
patient was operated on early in the series.
Patients with interrupted aortic arch. Associated inter-
rupted aortic arch was repaired in 9 patients. Eight patients
had type B and 1 patient had type A interrupted arch. The
median age was 17 days (range, 4 days–6 months). Seven
patients were younger than 1 month old, 1 was 6 weeks old,
and another was 6 months old. None of the patients with asso-
ciated interrupted aortic arch had truncal valve regurgitation.
After wide mobilization of the ascending and descending
aorta and control of the arch vessels, direct anastomosis was
Table I. Morphologic characteristics
Characteristic N
TVR 14
Mild 5
Moderate 5
Severe 4
IAA 9
Type A 1
Type B 8
Coronary anomalies 5
TVR, Truncal valve regurgitation; IAA, interrupted aortic arch.
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achieved in 5 patients. In the other 4 patients partial direct
anastomosis was augmented with a pericardial or homograft
gusset.
Statistical analysis. Median age, weight, and time to reop-
eration were compared by the Mann-Whitney U test.
Differences in CPB, crossclamp, and circulatory arrest times
were evaluated by the unpaired Student t test. The analysis of
reoperation was done with the Cox proportional hazard
model,8 using the following variables: age, weight at opera-
tion, sex, presence of truncal valve regurgitation, interrupted
aortic arch, CPB time, and crossclamp time. Percent survival
at 30 days, 1 year, and 3 years and freedom from reoperation
were determined by the Kaplan-Meier product-limit method
and a 95% confidence interval estimated by the Greenwood
formula.9 Two-tailed values of probability (P) were deter-
mined. Data analysis was done with the SPSS software pack-
age (version 8.0, SPSS Inc, Chicago, Ill).
Results
There were 2 perioperative deaths (4%) in 50 patients
who underwent repair of truncus arteriosus and associ-
ated lesions. One death occurred in the first year of this
series. This was in a 5-day-old boy weighing 2.9 kg
who had severe truncal valve regurgitation. He under-
went homograft root replacement with reimplantation
of the coronary arteries. CPB was ceased with admin-
istration of large doses of inotropic agents. The chest
was left open. In the early postoperative period, respi-
ratory failure and abdominal distension developed. An
attempt at insertion of a peritoneal dialysis catheter
resulted in liver hemorrhage. The patient died on post-
operative day 4.
The second death was in a 2-week-old boy weighing
3.5 kg. This patient had mild to moderate truncal valve
regurgitation and dual origin of the left anterior
descending coronary artery. After repair, the patient
was weaned from CPB with moderate support. He had
complete heart block and pacing was required. One
hour after arrival in the intensive care unit he had a car-
diac arrest and after resuscitation was placed on extra-
corporeal membrane oxygenation (ECMO) support.
There was no suggestion of tamponade or pulmonary
hypertensive crisis accounting for the arrest. The next
48 hours were complicated by severe coagulopathy and
bleeding. Transesophageal echocardiography revealed
poor left ventricular function and a thrombosed con-
duit. The patient was returned to the operating room for
replacement of the conduit and subsequently was main-
tained on ECMO support for a further 48 hours. His
course was complicated by Aspergillus mediastinitis. It
was also demonstrated that the excised homograft was
infected with Aspergillus. All attempts at weaning from
ECMO were unsuccessful and at this point the patient
had overwhelming sepsis. Resuscitation was ceased.
Patients with truncal valve regurgitation. There
were 2 deaths in the group of patients with truncal
valve regurgitation. Both cases were discussed in the
preceding section. Of the 5 patients who underwent
truncal valve repair, none died. Two patients had trans-
esophageal echocardiography done in the operating
room after weaning from CPB that showed minimal
valvular regurgitation. Transthoracic echocardiography
done after the operation in all patients having repair
showed mild valvular regurgitation in 2 patients and 3
patients had no truncal valve regurgitation.
Transthoracic echocardiography at the most recent
follow-up showed minimal valvular regurgitation in the
5 patients who underwent repair. Of the 8 patients who
did not undergo truncal valve repair or replacement, 5
with mild truncal valve regurgitation and 2 with mod-
erate truncal valve regurgitation did not have any dete-
rioration of valve function at follow-up. One patient
with moderate valvular regurgitation has had some
deterioration in valve function.
Patients with associated interrupted aortic arch.
There were no deaths in the group of patients with
associated interrupted aortic arch, and the median hos-
pital stay was not significantly different from the stay
in those patients without interrupted aortic arch.
Obstruction across the arch anastomosis was defined as
a pressure gradient of 30 mm Hg or greater defined by
Table II. CPB, crossclamp, and circulatory arrest times
Group n CPB (min) n Crossclamp (min) n Arrest (min)
All patients 50 128 (79-209) 50 68 (26-116) 15 33 (6-76)
TVR 14 110 (79-184) 14 67 (26-96) 2 18 (6-30)
No TVR 36 130 (84-209) 36 70 (44-116) 4 34 (19-76)
IAA 9 157 (131-209) 9 87 (72-116) 9 40 (22-76)
No IAA 41 121 (79-184)* 41 66 (26-102)* —
Values represent median time in minutes with ranges given in parentheses. Data from patients with and without truncal valve regurgitation (TVR) and interrupted aor-
tic arch (IAA) were compared for each of these variables.
*P < .001, Mann-Whitney U test; all other comparisons were not significant.
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transthoracic echocardiography. At follow-up, none of
the patients had any degree of arch obstruction.
Freedom from reoperation. Conduit replacement
has been done in 17 patients (34%) with a median inter-
val of 3 years. The median aortic homograft size at the
initial operation was 10 mm and the median pulmonary
homograft size was also 10 mm. The median time for
reoperation for patients who had an aortic homograft
was 4 years (range, 8 months–7 years) and for those
who had a pulmonary homograft, 3 years (range, 11
months–4 years). This difference was not significant (P
= .87). By the Cox proportional hazard model, patients
with a larger homograft size had a longer period of free-
dom from conduit replacement. None of the patients has
required reoperation because of truncal valve problems
or aortic arch stenosis. The actuarial survival was 96%
at 30 days, 1 year, and 3 years (Fig 1). Freedom from
reoperation is shown in Fig 2.
Fig 1. Kaplan-Meier time-related survival.
Fig 2. Kaplan-Meier time-related freedom from conduit replacement. The numbers of remaining patients at risk
are shown in parentheses at the appropriate points. Error bars represent the lower 95% confidence limits.
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Follow-up. The follow-up was complete in all 48
patients (median, 23 months; range, 1-60 months). The
mean follow-up for patients with interrupted aortic
arch was 13 months (range, 1-48 months) and for
patients with truncal valve regurgitation, 14 months
(range, 3-36 months).
Discussion
In this study, the more complex forms of truncus arte-
riosus, those with truncal valve regurgitation and asso-
ciated interrupted aortic arch, are analyzed. These asso-
ciated anomalies were previously identified as risk
factors for death after repair of truncus arteriosus.3
The disappointing results of truncal valve replace-
ment and the success of aortic valve repair in the adult
population have increased interest in the repair of trun-
cal valve insufficiency.10-12 In this study, 5 patients
underwent truncal valve repair. In all 5 patients, truncal
valve insufficiency was diagnosed preoperatively and
therefore valve repair was a planned procedure. In the
most recent previous series from Children’s Hospital,
Boston, 4 of 8 patients with truncal valve insufficiency
died. On further analysis of the 4 deaths, only 1 patient
had replacement as a planned part of the primary repair.
In another, valve replacement was done after failure to
wean from CPB. Two patients died in the perioperative
period before valve replacement could be accom-
plished. Of the 4 patients who survived, 2 underwent
perioperative valve replacement and 2 underwent
replacement at 6 and 12 months, respectively. In the
current series, none of the patients who underwent
truncal valve repair has required intervention at a medi-
an follow-up of 14 months (range, 3-36 months).
It is thought that nodular or dysmorphic valves are
more likely to be insufficient and have an abnormal
number of leaflets2 and that quadricusp valves are more
regurgitant than tricuspid valves.13 In this study, the
number of patients who underwent truncal valve repair
is too small to extrapolate as to which type of valve
would best be served by valvuloplasty techniques.
Most probably, conversion of a quadricusp valve to a
tricuspid valve will be most productive, because it will
restore a trileaflet morphology. It may be that repair
resulting in bicuspid morphology would predispose to
future valve stenosis.
The results of truncal valve replacement have been
disappointing. In the current series, the 1 patient who
underwent truncal valve replacement because of valve
regurgitation died in the postoperative period. Elkins
and colleagues7 have reported the cases of 4 patients
who underwent homograft replacement of the truncal
valve, 2 of whom died in the early postoperative peri-
od. In a report by McElhinney and colleagues,14 3 of
the 4 neonates who received allograft root replacement
died within 7 months after repair and the fourth
required replacement after 1 year because of severe
homograft insufficiency. Four of their 6 patients who
required mechanical valve replacement died in the
early postoperative period. The risks of mechanical
valve replacement in the small truncal root, impairing
normal growth of the native anulus as well as subject-
ing the child to long-term anticoagulation, should be
weighed against potential benefits.
The results in this series with associated interrupted
arch have improved significantly compared with results
in the previous report,3 in which 3 of 6 patients died
after repair. There were no deaths in the 9 patients who
underwent complete repair. Of the 9 patients who
underwent repair, 7 were younger than 1 month old.
We advocate direct anastomosis between the ascend-
ing and the descending aorta. A gusset of homograft can
be used for augmentation of the anastomosis if there is
important size disparity. Others have suggested the use
of subclavian artery in type A interrupted aortic arch
and the use of both the subclavian and the left carotid
arteries in type B interrupted aortic arch.15 In this
method, the arch vessels are divided distally and then
filleted open to form the superior part of the neo-aortic
arch. Those authors believe that the risk of stenosis is
reduced. However, this has to be balanced against the
risk of cerebral damage.16 At a mean follow-up of 13
months (range, 1-48 months), none of the patients in our
series has been seen because of restenosis. Although the
follow-up is too short in this group to draw any infer-
ences regarding the method of repair, it is unlikely that
circumferential anastomosis per se will result in steno-
sis, as has been shown in infants and neonates who have
undergone the arterial switch operation.17
In conclusion, despite the magnitude of this opera-
tion, excellent results can be achieved in complex
forms of truncus arteriosus. We advocate complete one-
stage repair in these patients. In patients with truncal
valve regurgitation, valve repair is a preferable option
to valve replacement. In the current era, associated
interrupted aortic arch may no longer be associated
with increased mortality in patients undergoing repair
of truncus arteriosus.
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Discussion
Dr Edward L. Bove (Ann Arbor, Mich). Dr Jonas and his
associates from Boston have presented an outstanding series
of repair of truncus arteriosus, demonstrating that excellent
outcomes can be expected in the modern era for this condi-
tion, even with associated interrupted aortic arch and truncal
valve regurgitation.
Not long ago many authors, including those from the cur-
rent report, found that repair of truncus arteriosus was associ-
ated with a higher mortality when there was coexisting arch
interruption or truncal valve regurgitation. Why are the results
better now? Although the answers are not always readily
apparent from a retrospective data review, it seems clear that
a number of factors, including earlier age at operation, better
preoperative and postoperative management, and increased
experience with the repair of arch abnormalities of all kinds
in neonates, have played significant roles.
Importantly, however, the results presented today also indi-
cate that truncal valve repair is a particularly useful option in
the management of significant truncal valve regurgitation.
This knowledge will allow surgeons to avoid the delay in
operation that has so often been used when the truncal valve
must be dealt with and also to avoid the technical complexi-
ty introduced by truncal valve replacement itself, thus remov-
ing arguably the two most significant risk factors associated
with the need for truncal valve replacement.
A few years ago, our group reported excellent survival with
severe truncal valve regurgitation when truncal valve replace-
ment was undertaken without delay, even in neonates, indi-
cating that delaying the operation plays an important role in
the outcome, as also demonstrated for uncomplicated trun-
cus, and that operating on a patient with worsening left ven-
tricular dysfunction and in poor preoperative condition was
itself associated with a higher risk. Thus prompt truncal valve
replacement can be done satisfactorily. However, the prob-
lems associated with the need for repeated replacement of the
truncal valve in growing babies present yet another set of
risks that can and should be avoided by early valve repair as
demonstrated by the authors. However, although it appears
that repair is possible even in severely malformed valves, the
limitations of this technique are not fully understood.
Similarly outstanding results can now be expected with
associated interruption of the arch, a condition that has not
posed an increased risk in our institution for a considerable
time. The authors prefer a primary anastomosis, a technique
with which we would agree, although arch augmentation with
a homograft patch is another useful tool that allows for a bet-
ter size match between the distal aorta and the often small
segment of ascending aorta that is left after removal of the
duct and the pulmonary arteries. We have increasingly used
the Lecompte maneuver to translocate the branch pulmonary
arteries anteriorly to facilitate conduit placement.
I have three main questions for Dr Jonas. First, you used
repair of the truncal valve in 5 of the 9 patients in your series
who had at least moderate regurgitation. Although no doubt
your indications were evolving over time, could you tell us
why the other 4 patients were not treated in a similar fashion
and what their postoperative outcomes and echocardiograms
showed? Do you now recommend repair for any patient with
at least moderate regurgitation?
Second, have you identified any morphologic characteris-
tics of the truncal valve that may be predictive of successful
repair? In particular, what about those valves that are very
immobile, often with significant degrees of stenosis? It has
certainly been our experience that patients with severe trun-
cal valve regurgitation also have gradients across the valve,
admittedly because of the large volume flow, but often also
because of the very thickened and immobile leaflets.
Finally, have you seen any bronchial obstruction after your
technique of repair of the interrupted aortic arch?
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Dr Jonas. The reason that all patients with at least moder-
ate regurgitation did not have repair is that this has been a
combined experience of several surgeons. I have been enthu-
siastic about truncal valve repair for some time, but I believe
now all of us in Boston are catching on to this idea.
I think your second point is one of the important reasons
we have started to become more enthusiastic, and that is
because of an appreciation that gradients detected across
these valves preoperatively are usually eliminated by elimi-
nating the regurgitation. The same has been true with aortic
valve repairs as well in that much of the supposed stenosis is
in fact an artifact and simply a reflection of the huge volume
load that these valves are carrying before operation.
Remember that not only are truncal valves carrying the regur-
gitant fraction but they are also carrying the entire pulmonary
blood flow. I personally have yet to see a valve that has had
fixed immobile leaflets that would not be suitable for repair.
Perhaps they do exist and perhaps one would not be able to
repair them, but I think they are rare.
As to the status of the patients with moderate regurgitation
who did not receive repair, I would like to call on Dr
Jahangiri to comment. As far as I am aware, none has re-
quired a subsequent valve operation, so I believe that they
have remained in stable condition. However, certainly our
threshold for repairing valves is constantly coming down and
that applies to both aortic valves and truncal valves.
Regarding bronchial obstruction, I think we learned a
long time ago with simple interrupted aortic arch that very
wide mobilization of the descending aorta and the arch
vessels is important, and that one has to bring the head ves-
sels down as well as bring the descending aorta up to the
anastomosis. This helps reduce the tension on the anasto-
mosis, which fundamentally is the cause of left bronchial
obstruction.
I believe also the concept of dividing the truncus rather
than taking the pulmonary arteries off the side is important.
Often a major bulge out of the left side of the truncus will
result if you simply take the pulmonary arteries off.
Especially if you have essentially type I truncus and simply
take the pulmonary arteries off, leaving the ascending aorta in
continuity, then the routing of the conduit becomes complex
and can result in compression of the conduit, compression of
the coronary arteries, and so on. I think by shifting the whole
trunk rightward by doing a complete division, and also tai-
loring the rest down to improve the valve, one avoids obstruc-
tive problems all around.
Dr V. Mohan Reddy (San Francisco, Calif). Dr Jahangiri
and Dr Jonas and their group have shown excellent results. I
definitely agree with their conclusion. Our experience says
that truncal valve repair is the preferred treatment in these
patients. In our early experience, we tended to use allograft
replacement. Certainly all the patients survived, but within a
few months severe allograft regurgitation developed, and we
subsequently gave up using allografts in favor of repair. I
would like to ask Dr Jonas what happened to the one patient
in whom you had replaced the truncal valve with an allograft?
Dr Jonas. Dr Jahangiri, can you clarify that for us? I do not
recall reoperating on that patient, but certainly we have seen
accelerated calcification when we have used homografts. Did
that patient require reoperation?
Dr Jahangiri. That patient was one of those who died in
the series. We had to leave the chest open because the heart
was swollen with increasing edema. The patient was sent to
the intensive care unit and required considerable inotropic
support. Subsequently, in the next 48 hours, candidiasis
developed and the patient died of uncontrolled sepsis.
Dr Reddy. I would like to add a cautionary note. When
allografts were placed in neonates with associated very
severe regurgitation, allograft regurgitation developed within
3 months. We did this procedure in 4 patients early in our
experience and all of them required replacement within the
first 6 months.
